A Study of Intravenous M1-c6v1 for Locally Advanced or Metastatic Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 10, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

December 20, 2026

Conditions
Solid Tumor
Interventions
BIOLOGICAL

M1-c6v1

Intravenous drip administration

Trial Locations (3)

Unknown

RECRUITING

National Cancer Center Hospital East, Kashiwa-shi

RECRUITING

National Hospital Organization Shikoku Cancer Center, Matsuyama

RECRUITING

St. Marianna University Hospital, Kawasaki-shi

All Listed Sponsors
lead

Guangzhou Virotech Pharmaceutical Co., Ltd.

INDUSTRY

NCT06046742 - A Study of Intravenous M1-c6v1 for Locally Advanced or Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter